Penserra Capital Management LLC Forma Therapeutics Holdings, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$13.6 - $24.89 $14,756 - $27,005	-1,085 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $106 - $128	5 Added 0.46%	1,085 $25,000
Q2 2021 Aug 12, 2021	BUY	$22.86 - $30.95 $1,600 - $2,166	70 Added 6.93%	1,080 $26,000
Q1 2021 May 13, 2021	BUY	$24.58 - $42.82 $1,597 - $2,783	65 Added 6.88%	1,010 $28,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $32,980 - $48,270	945 New	945 $32,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.